Phenotypic and Molecular Detection for Antibiotic Resistance of Enterobacter cloacae Isolated from Urinary Tract Infections
Abstract
Introduction: Enterobacter cloacae has emerged as a significant pathogen in urinary tract infections, particularly in hospitals under antibiotic pressure, resulting in rapid development of resistance. The number of mechanisms, including β-lactamase production, aminoglycoside-modifying enzymes, efflux systems, and plasmid-mediated determinants used by the organism, made successful treatment difficult. Phenotypic resistance interpretation and the detection of widely used genetic markers are key components that drive therapy and contain the transmission of MDR strains. Methods: A total of 100 urine samples were obtained from patients with UTI at three hospitals in Babylon province from November 2024 to January 2025. Isolates were confirmed as E. cloacae by routine culture and biochemical tests. Susceptibility to antimicrobial agents was determined by the CLSI disc diffusion method. All isolates were tested for AcrAB, blaTEM, strA, and tetA using molecular detection assays, whereas 16S rRNA gene sequencing was performed to validate species identification and assess genetic diversity among isolates. Results: The isolates exhibited high-level resistance to amoxicillin-clavulanate (100%), ceftazidime (100%), and tetracycline (90%). Resistance to ampicillin, clarithromycin, erythromycin, and streptomycin was also higher. Gentamicin and ciprofloxacin demonstrated moderate activity, whereas levofloxacin and high-level streptomycin were most potent. The most common were AcrAB (80%),…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.